BIOMAT Database Logo BIOMAT Database Logo

Savoxepine: striatal dopamine-D2 receptor occupancy in human volunteers measured using positron emission tomography (PET). 1993

K L Leenders, and A Antonini, and R Thomann, and J T Locher, and L Maître, and A Gerebtzoff, and H F Beer, and S Ametamey, and R Weinreich, and A Gut
PET Program, Paul-Scherrer Institut (PSI), Villigen, Switzerland.

The extent and duration of striatal dopamine-D2 receptor occupancy by savoxepine in humans has been studied using positron emission tomography with [11C]-raclopride, in order to investigate why the anticipated favourable ratio between its extrapyramidal and antipsychotic effects was not achieved in practice. After 0.25 mg savoxepine, striatal D2 receptor occupancy peaked at 50-60% after 24-36 h and disappeared within 6 days. After doses of 0.1 mg to 0.5 mg, D2 receptor occupancy in the putamen and caudate nucleus increased from 20 to 70% 3-7 h after administration and amounted to 40 to 75% at the peak time (20-29 h). This suggests that cumulative D2 receptor blockade would occur if equal or increasing doses of savoxepine were given repeatedly. Extrapyramidal adverse-effects would be likely to occur under such circumstances. An adequate test of the theory that preference for hippocampal dopamine D2 receptors with afford a good therapeutic ratio requires an alternative dosing regimen.

UI MeSH Term Description Entries
D007553 Isotope Labeling Techniques for labeling a substance with a stable or radioactive isotope. It is not used for articles involving labeled substances unless the methods of labeling are substantively discussed. Tracers that may be labeled include chemical substances, cells, or microorganisms. Isotope Labeling, Stable,Isotope-Coded Affinity Tagging,Isotopically-Coded Affinity Tagging,Affinity Tagging, Isotope-Coded,Affinity Tagging, Isotopically-Coded,Isotope Coded Affinity Tagging,Labeling, Isotope,Labeling, Stable Isotope,Stable Isotope Labeling,Tagging, Isotope-Coded Affinity,Tagging, Isotopically-Coded Affinity
D008297 Male Males
D011699 Putamen The largest and most lateral of the BASAL GANGLIA lying between the lateral medullary lamina of the GLOBUS PALLIDUS and the EXTERNAL CAPSULE. It is part of the neostriatum and forms part of the LENTIFORM NUCLEUS along with the GLOBUS PALLIDUS. Nucleus Putamen,Nucleus Putamens,Putamen, Nucleus,Putamens,Putamens, Nucleus
D002421 Caudate Nucleus Elongated gray mass of the neostriatum located adjacent to the lateral ventricle of the brain. Caudatus,Nucleus Caudatus,Caudatus, Nucleus,Nucleus, Caudate
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D003989 Dibenzoxazepines
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012457 Salicylamides Amides of salicylic acid.

Related Publications

K L Leenders, and A Antonini, and R Thomann, and J T Locher, and L Maître, and A Gerebtzoff, and H F Beer, and S Ametamey, and R Weinreich, and A Gut
Serotonergic modulation of striatal D2 dopamine receptor binding in humans measured with positron emission tomography.
August 1996, Psychopharmacology,
K L Leenders, and A Antonini, and R Thomann, and J T Locher, and L Maître, and A Gerebtzoff, and H F Beer, and S Ametamey, and R Weinreich, and A Gut
In vivo quantification of striatal dopamine D2 receptor occupancy by JNJ-37822681 using [11C]raclopride and positron emission tomography.
August 2012, Journal of psychopharmacology (Oxford, England),
K L Leenders, and A Antonini, and R Thomann, and J T Locher, and L Maître, and A Gerebtzoff, and H F Beer, and S Ametamey, and R Weinreich, and A Gut
Positron emission tomography finding of a high striatal D2 receptor occupancy in olanzapine-treated patients.
March 1998, Archives of general psychiatry,
K L Leenders, and A Antonini, and R Thomann, and J T Locher, and L Maître, and A Gerebtzoff, and H F Beer, and S Ametamey, and R Weinreich, and A Gut
A positron emission tomography (PET) investigation of the role of striatal dopamine (D2) receptor availability in spatial cognition.
October 2005, NeuroImage,
K L Leenders, and A Antonini, and R Thomann, and J T Locher, and L Maître, and A Gerebtzoff, and H F Beer, and S Ametamey, and R Weinreich, and A Gut
Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis.
January 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience,
K L Leenders, and A Antonini, and R Thomann, and J T Locher, and L Maître, and A Gerebtzoff, and H F Beer, and S Ametamey, and R Weinreich, and A Gut
Predicting the dopamine D2 receptor occupancy of ropinirole in rats using positron emission tomography and pharmacokinetic-pharmacodynamic modeling.
February 2019, Xenobiotica; the fate of foreign compounds in biological systems,
K L Leenders, and A Antonini, and R Thomann, and J T Locher, and L Maître, and A Gerebtzoff, and H F Beer, and S Ametamey, and R Weinreich, and A Gut
Positron emission tomography study of human narcolepsy: no increase in striatal dopamine D2 receptors.
September 1995, Neurology,
K L Leenders, and A Antonini, and R Thomann, and J T Locher, and L Maître, and A Gerebtzoff, and H F Beer, and S Ametamey, and R Weinreich, and A Gut
Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography.
February 1994, Archives of general psychiatry,
K L Leenders, and A Antonini, and R Thomann, and J T Locher, and L Maître, and A Gerebtzoff, and H F Beer, and S Ametamey, and R Weinreich, and A Gut
Positron emission tomography studies on D2 dopamine receptor occupancy and plasma antipsychotic drug levels in man.
September 1995, International clinical psychopharmacology,
K L Leenders, and A Antonini, and R Thomann, and J T Locher, and L Maître, and A Gerebtzoff, and H F Beer, and S Ametamey, and R Weinreich, and A Gut
Reproducibility of striatal and thalamic dopamine D2 receptor binding using [11C]raclopride with high-resolution positron emission tomography.
January 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,
Copied contents to your clipboard!